PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
+5.72%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$1.4B
AUM Growth
+$1.4B
(-3%)
Cap. Flow
-$128M
Cap. Flow
% of AUM
-9.15%
Top 10 Holdings %
Top 10 Hldgs %
38.07%
Holding
267
New
41
Increased
25
Reduced
70
Closed
46
Top Buys
| 1 |
ATAI Life Sciences
ATAI
|
$23.2M |
| 2 |
Agilon Health
AGL
|
$15.6M |
| 3 |
Privia Health
PRVA
|
$15.4M |
| 4 |
Eli Lilly
LLY
|
$15.1M |
| 5 |
Lantheus
LNTH
|
$14.8M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$23.9M |
| 2 |
Vericel Corp
VCEL
|
$20.8M |
| 3 |
Align Technology
ALGN
|
$19M |
| 4 |
SI-BONE Inc
SIBN
|
$17.5M |
| 5 |
STAAR Surgical
STAA
|
$16.8M |
Sector Composition
| 1 | Healthcare | 79.46% |
| 2 | Industrials | 3.16% |
| 3 | Materials | 1.25% |
| 4 | Financials | 1.11% |
| 5 | Consumer Staples | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZY
51
DELISTED
Zymergen Inc. Common Stock
ZY
| $8.59M | 0.27% | +214,577 | New | +$8.59M |
|
52
Alpha Teknova
TKNO
$231M
| $8.31M | 0.26% | +350,000 | New | +$8.31M |
|
53
Seer Inc
SEER
$115M
| $8.3M | 0.26% | 253,041 -8,882 | -3% | -$291K |
|
54
Guardant Health
GH
$8.41B
| $8.23M | 0.26% | 66,240 -37,668 | -36% | -$4.68M |
|
55
Zimmer Biomet
ZBH
$21B
| $8.04M | 0.25% | 50,000 -48,948 | -49% | -$7.87M |
|
56
The Beauty Health Co
SKIN
$264M
| $7.39M | 0.23% | +439,766 | New | +$7.39M |
|
57
Bionano Genomics
BNGO
$17.6M
| $7.33M | 0.23% | 1,000,000 | – | – |
|
|
CMPS
58
Compass Pathways
CMPS
$424M
| $7.25M | 0.23% | 190,071 +81,925 | +76% | +$3.13M |
|
59
CVRx
CVRX
$205M
| $7M | 0.22% | +250,000 | New | +$7M |
|
|
MRTX
60
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $6.38M | 0.2% | 39,522 +9,280 | +31% | +$1.5M |
|
61
908 Devices
MASS
$226M
| $6.24M | 0.19% | 161,059 +12,292 | +8% | +$476K |
|
62
Cullinan Oncology
CGEM
$445M
| $6.2M | 0.19% | 240,798 +24,168 | +11% | +$622K |
|
|
ARYD
63
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
| $5.74M | 0.18% | 535,179 -8,985 | -2% | -$96.3K |
|
64
Regeneron Pharmaceuticals
REGN
$61.5B
| $5.59M | 0.17% | +10,000 | New | +$5.59M |
|
65
Neuropace
NPCE
$303M
| $5.45M | 0.17% | +229,264 | New | +$5.45M |
|
|
ICAD
66
DELISTED
iCAD Inc
ICAD
| $5.37M | 0.17% | 310,278 -77,915 | -20% | -$1.35M |
|
67
Avita Medical
RCEL
$117M
| $5.31M | 0.17% | 258,951 -124,638 | -32% | -$2.56M |
|
|
CMLTU
68
DELISTED
CM Life Sciences III Inc. Unit
CMLTU
| $5.29M | 0.16% | +483,164 | New | +$5.29M |
|
|
RACB
69
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
| $5.28M | 0.16% | 520,180 -13,120 | -2% | -$133K |
|
|
NVRO
70
DELISTED
NEVRO CORP.
NVRO
| $4.97M | 0.15% | +30,000 | New | +$4.97M |
|
71
Zentalis Pharmaceuticals
ZNTL
$122M
| $4.85M | 0.15% | 91,069 +34,293 | +60% | +$1.82M |
|
72
Glaukos
GKOS
$5.5B
| $4.67M | 0.15% | 55,000 -37,500 | -41% | -$3.18M |
|
|
CMAX
73
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $4.67M | 0.15% | 361,627 -5,387 | -1% | -$69.5K |
|
|
AKYA
74
DELISTED
Akoya BioSciences
AKYA
| $4.63M | 0.14% | +239,566 | New | +$4.63M |
|
75
Turning Point Brands
TPB
$1.79B
| $4.63M | 0.14% | 101,059 -116,484 | -54% | -$5.33M |
|